1. Cell Signaling by Receptor Tyrosine Kinases
2. Epidermal Growth Factor Receptor Targeting in Cancer
3. ErbituxR (Cetuximab) package insert. ImClone Systems Incorporated, New York, N.Y. and Bristol-Myers Squibb Company, Princeton, N.J., August 2006.
4. Tarceva (erlotinib) tablets (package insert). Genentech, Inc., South San Francisco, Calif., and OSI Pharmaceuticals Inc., Melville, N.Y., May 2007.
5. National Cancer Institute Drug Information: FDA approval for gefitinib, brand name(s): IressaR. www.cancer.gov/cancertopics/druginfo/fda-gefitinib (accessed June 15, 2007).